This inventor holds 2 USPTO granted patents. Top assignee: Northwestern University. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2010
Title: Michael C. Myers: Innovator in Tumor Suppressor Reactivation
Introduction
Michael C. Myers is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of cancer research, particularly in the reactivation of tumor suppressor proteins. With a total of 2 patents, his work focuses on innovative compounds that have the potential to impact cancer treatment.
Latest Patents
Among his latest patents, Michael has developed compounds and related methods for mutant p53 reactivation. His work on ketoamine compounds aims to reactivate the tumor suppressor protein p53, which is crucial in preventing cancer cell proliferation. This innovative approach could lead to new therapeutic strategies for patients with p53 mutations.
Career Highlights
Michael C. Myers is affiliated with Northwestern University, where he conducts his research. His academic background and ongoing research projects have positioned him as a key figure in the study of tumor suppressor proteins. His dedication to advancing cancer treatment through innovative research is commendable.
Collaborations
Michael collaborates with Daniel H. Appella, enhancing the scope and impact of his research. Their combined expertise contributes to the development of effective methods for cancer treatment.
Conclusion
Michael C. Myers is a pioneering inventor whose work in tumor suppressor reactivation holds promise for future cancer therapies. His contributions to the field are significant and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile